Publish in this journal
Journal Information
Vol. 71. Issue 8.
Pages 691 (August 2018)
Share
Share
Download PDF
More article options
Vol. 71. Issue 8.
Pages 691 (August 2018)
Corrections
DOI: 10.1016/j.rec.2018.04.018
Full text access
Correction in the article by Ponikowski et al. “2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure”, Rev Esp Cardiol. 2016;69:1167.e1-e85
Corrección en el artículo de Ponikowski et al. «Guía ESC 2016 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica», Rev Esp Cardiol. 2016;69:1167.e1-e85
Visits
...
Article information
Full Text

The European Society of Cardiology reports a correction in the article by Ponikowski et al. entitled, “2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure”, whose Spanish translation was published in Rev Esp Cardiol. 2016;69:1167.e1-e85.

In section 11.6, in paragraph 5, the sentence: ‘Dipeptidylpeptidase-4 inhibitors (DPP4is; gliptins), which increase incretin secretion, thereby stimulating insulin release, and longacting glucagon-like peptide 1 (GLP-1) receptor agonists, which act as incretin mimetics, improve glycaemic indices but do not reduce and may increase the risk of cardiovascular events and worsening HF.’ was amended to: ‘Dipeptidylpeptidase-4 inhibitors (DPP4is; gliptins), which increase incretin levels by reducing its degradation, thereby stimulating insulin release, and longacting glucagon-like peptide 1 (GLP-1) receptor agonists, which act as incretin mimetics, improve glycaemic indices but do not reduce and may increase the risk of cardiovascular events and worsening HF.’

The paper has now been corrected online.

Copyright © 2018. Sociedad Española de Cardiología
Idiomas
Revista Española de Cardiología (English Edition)

Subscribe to our newsletter

Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?